Adolescent Initiation of Cannabis Use and Early-Onset Psychosis

REFERENCES

• Kaminer Y, Bukstein O, eds. Adolescent Substance Abuse: Psychiatric Comorbidity and High-Risk Behaviors. New York, NY: Routledge; 2008.
   Google Scholar
• Hovens JG, Cantwell DP, Kiriakos R. Psychiatric comorbidity in hospitalized adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1994;33:476–483.
   PubMed Web of Science ®Google Scholar
• Mazzoncini R, Donoghue K, Hart J, et al. Illicit substance use and its correlates in first episode psychosis. Acta Psychiatr Scand. 2010;121:351–358.
   PubMed Web of Science ®Google Scholar
• Lambert M, Conus P, Lubman DI, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand. 2005;112:141–148.
   PubMed Web of Science ®Google Scholar
• Korkeila JA, Svirskis T, Heinimaa M, et al. Substance abuse and related diagnoses in early psychosis. Compr Psychiatry. 2005;46:447–452.
   PubMed Web of Science ®Google Scholar
• Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry. 2006;189:229–234.
   PubMed Web of Science ®Google Scholar
• Sorbara F, Liraud F, Assens F, Abalan F, Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry. 2003;18:133–136.
   PubMed Web of Science ®Google Scholar
• Gururajan A, Manning EE, Klug M, van den Buuse M. Drugs of abuse and increased risk of psychosis development. Aust N Z J Psychiatry. 2012;46:1120–1135.
   PubMed Web of Science ®Google Scholar
• Schepis TS, Adinoff B, Rao U. Neurobiological processes in adolescent addictive disorders. Am J Addict. 2008;17:6–23.
   PubMed Web of Science ®Google Scholar
• Kleber HD, DuPont RL. Physicians and medical marijuana. Am J Psychiatry. 2012;169:564–568.
   PubMed Web of Science ®Google Scholar
• Wang GS, Roosevelt G, Le Lait MC, et al. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Ann Emerg Med. 2014;63:684–689.
   Web of Science ®Google Scholar
• Wu LT, Brady KT, Mannelli P, Killeen TK. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014;50:26–35.
   PubMed Web of Science ®Google Scholar
• Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;2:1483–1486.
   PubMed Web of Science ®Google Scholar
• Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005;31:608–612.
   PubMed Web of Science ®Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319–328.
   PubMed Web of Science ®Google Scholar
• Ongur D, Lin L, Cohen BM. Clinical characteristics influencing age at onset in psychotic disorders. Compr Psychiatry. 2009;50:13–19.
   PubMed Web of Science ®Google Scholar
• Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68:555–561.
   PubMed Web of Science ®Google Scholar
• Galvez-Buccollini JA, Proal AC, Tomaselli V, et al. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res. 2012;139:157–160.
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212–1213.
   PubMed Web of Science ®Google Scholar
• Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004;99:1333–1341.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003;33:15–21.
   PubMed Web of Science ®Google Scholar
• Cougnard A, Marcelis M, Myin-Germeys I, et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med. 2007;37:513–527.
   PubMed Web of Science ®Google Scholar
• Kuepper R, van Os J, Lieb R, Wittchen HU, Hofler M, Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ. 2011;342:d738.
   PubMed Web of Science ®Google Scholar
• Schubart CD, van Gastel WA, Breetvelt EJ, et al. Cannabis use at a young age is associated with psychotic experiences. Psychol Med. 2011;41:1301–1310.
   PubMed Web of Science ®Google Scholar
• Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev. 2000;31:371–384.
   PubMed Web of Science ®Google Scholar
• Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep. 2002;4:177–184.
   PubMedGoogle Scholar
• Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003;69:303–310.
   PubMed Web of Science ®Google Scholar
• D'Souza DC, Abi-Saab WM, Madonick S, et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry. 2005;57:594–608.
   PubMed Web of Science ®Google Scholar
• Kumra S, Robinson P, Tambyraja R, et al. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry. 2012;51:171–180.
   PubMed Web of Science ®Google Scholar
• Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57:1117–1127.
   PubMed Web of Science ®Google Scholar
• Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004;29:1943–1961.
   PubMed Web of Science ®Google Scholar
• Lewis DA. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology. 1997;16:385–398.
   PubMed Web of Science ®Google Scholar
• Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci. 2013;263:3–13.
   PubMed Web of Science ®Google Scholar
• Rapp C, Bugra H, Riecher-Rossler A, Tamagni C, Borgwardt S. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des. 2012;18:5070–5080.
   PubMed Web of Science ®Google Scholar
• Rais M, Cahn W, Van Haren N, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry. 2008;165:490–496.
   PubMed Web of Science ®Google Scholar
• Johnston LD OMP, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2012. Ann Arbor: Institute for Social Research, The University of Michigan; 2013.
   Google Scholar
• Baeza I, Graell M, Moreno D, et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009;113:129–137.
   PubMed Web of Science ®Google Scholar
• McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67:440–447.
   PubMed Web of Science ®Google Scholar
• Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry. 2006;188:237–242.
   PubMed Web of Science ®Google Scholar
• Green AI, Tohen MF, Hamer RM, et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res. 2004;66:125–135.
   PubMed Web of Science ®Google Scholar
• Leeson VC, Harrison I, Ron MA, Barnes TR, Joyce EM. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull. 2012;38:873–880.
   PubMed Web of Science ®Google Scholar
• Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry. 2012;27:463–469.
   PubMed Web of Science ®Google Scholar
• de la Serna E, Mayoral M, Baeza I, et al. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers. J Nerv Ment Dis. 2010;198:159–162.
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330:11–25.
   Google Scholar
• Compton MT, Broussard B, Ramsay CE, Stewart T. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis. Schizophr Res. 2011;126:71–76.
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325:1199–1203.
   Google Scholar
• Kristensen K, Cadenhead KS. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res. 30 2007;151:151–154.
   PubMed Web of Science ®Google Scholar
• Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr Scand. 2008;118:209–213.
   PubMed Web of Science ®Google Scholar
• Miettunen J, Tormanen S, Murray GK, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry. 2008;192:470–471.
   PubMed Web of Science ®Google Scholar
• Auther AM, McLaughlin D, Carrion RE, Nagachandran P, Correll CU, Cornblatt BA. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med. 2012;42:2485–2497.
   PubMed Web of Science ®Google Scholar
• Yucel M, Bora E, Lubman DI, et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull. 2012;38:316–330.
   PubMed Web of Science ®Google Scholar
• Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res. 2005;133:35–43.
   PubMed Web of Science ®Google Scholar
• Wade D. Cannabis use and schizophrenia. Am J Psychiatry. 2005;162:401; author reply 402.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20:359–364.
   PubMed Web of Science ®Google Scholar
• Grech A, Van Os J, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry. 2005;20:349–353.
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand. 2007;115:304–309.
   PubMed Web of Science ®Google Scholar
• Jacobus J, Bava S, Cohen-Zion M, Mahmood O, Tapert SF. Functional consequences of marijuana use in adolescents. Pharmacol Biochem Behav. 2009;92:559–565.
   PubMed Web of Science ®Google Scholar
• Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res. 2005;75:135–137.
   PubMed Web of Science ®Google Scholar
• Rabin RA, Zakzanis KK, George TP. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res. 2011;128:111–116.
   PubMed Web of Science ®Google Scholar
• Meyer RE. Psychobiology and the treatment of drug dependence: the biobehavioral interface. Am J Drug Alcohol Abuse. 1986;12:223–233.
   PubMed Web of Science ®Google Scholar
• Milin R, Walker S, Duffy A. Assessment and treatment of comorbid psychotic disorders and bipolar disorder. In: Kaminer Y, Winters K, ed. Clinical Manual of Adolescent Substance Abuse Treatment. Washington, DC: American Psychiatric Publishing, Inc.; 2011:379–414.
   Google Scholar